))
Discussing Evaporative Dry Eye: Incorporating New Treatments Into Practice (CME/CE)
Manage episode 393352185 series 3453910
Sisällön tarjoaa MedEdicus. MedEdicus tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Access the disclosures, evaluation, and your CME credit via:
https://courses.mededicus.com/content/discussing-evaporative-dry-eye-incorporating-new-treatments-practice-cmece-podcast
This podcast with Dr. Ken Beckman and Dr. Jaclyn Garlich delves into presentation and treatments of evaporative dry eye primarily caused by meibomian gland dysfunction (MGD). It explores the multifactorial nature of dry eye disease (DED), emphasizing the significance of MGD-driven DED, characterized by a deficient tear lipid layer. The discussion focuses on the latest treatment options, moving beyond traditional anti-inflammatory therapies to include newer topical solutions targeting evaporative loss. Real patient case studies contextualize these innovative approaches in the clinical management of DED.
After completing this activity, participants will be better able to:
- Incorporate diagnostic strategies that examine meibomian gland function in routine practice
- Design evidence-based treatment plans for persons with meibomian gland dysfunction–associated dry eye disease
6 jaksoa
Jaa
